[1] 周丕琪, 沈霖, 杜靖远, 杨艳萍, 谢晶, 高兰, 刘保平. 绝经后骨质疏松症与血清IL-6，TNF-α浓度关系的临床研究 [J]. 中国骨质疏松杂志 2001.doi:10.3969/j.issn.1006-7108.2001.01.001
[2] 黄昶荃, 程刚, 陈建梅, 肖谦. 胰岛素抵抗对2型糖尿病及单纯胰岛素抵抗老龄大鼠的肾损伤和骨密度的影响 [J]. 中国老年学杂志 2006.doi:10.3969/j.issn.1005-9202.2006.04.031
[3] Rachon D. Role of tumor necrosis factor(TNF) and inter-leukin-6 (IL-6) in the pathogenesis of late complications of menopause.Effects of hormone replacement therapy on TNF and IL-6 expression [J]. Pol Merkuriusz Lek 2005, 18(108).
[4] Elizabeth B C, Donna K S. Does hyperinsuline mia preserve bone [J]. Diabetes Care 2000, 19.
[5] Luo Xianghang, Guo Lijuan, Yuan Lingqing. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway [J]. Experimental Cell Research 2005, 309(01).
[6] Luo Xianghang, Guo Lijuan, Xie Hui. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts via the MAPK signaling pathway [J]. J Bone M iner Res 2006, 21(10).
[7] Jurimae J, Jurimae T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. [J]. American Journal of Physiology 2007, 1(1).
[8] Richards JB, Valdes AM, Burling K, Perks UC, Spector TD. Serum adiponectin and bone mineral density in women. [J]. The Journal of Clinical Endocrinology and Metabolism 2007, 4(4).
[9] Takagi M, Kasayama S, Yamamoto T, Motomura T, Hashimoto K, Yamamoto H, Sato B, Okada S, Kishimoto T. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. [J]. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 1997, 3(3). |
